Treatment Timing, EEG, Neuroimaging, and Outcomes After Acute Necrotizing Encephalopathy in Children

J Child Neurol. 2021 Jun;36(7):517-524. doi: 10.1177/0883073820984063. Epub 2021 Jan 4.

Abstract

Background: Acute necrotizing encephalopathy (ANE) is a rare condition associated with rapid progression to coma and high incidence of morbidity and mortality.

Methods: Clinical, electroencephalographic (EEG), and brain magnetic resonance imaging (MRI) characteristics and immunomodulatory therapy timing were retrospectively analyzed in children with ANE. ANE severity scores (ANE-SS) and MRI scores were also assessed. The associations of patient characteristics with 6-month modified Rankin scale (mRS) and length of hospitalization were determined using either univariate linear regression or one-way analysis of variance.

Results: 7 children were retrospectively evaluated. Normal EEG sleep spindles (P = .024) and early treatment (R2 = .57, P = .030) were associated with improved outcomes (ie, decreased mRS). Higher ANE-SS (R2 = .79, P = .011), higher age (R2 = .62, P = .038), and presence of brainstem lesions (P = .015) were associated with longer length of hospitalization. Other patient characteristics were not significantly associated with mRS or length of hospitalization.

Conclusion: Early immunomodulatory therapy and normal sleep spindles are associated with better functional outcome in children with ANE.

Keywords: EEG; MRI; genetics; neuroimmunology; seizures.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Electroencephalography
  • Female
  • Humans
  • Immunomodulation*
  • Infant
  • Length of Stay
  • Leukoencephalitis, Acute Hemorrhagic / diagnosis*
  • Leukoencephalitis, Acute Hemorrhagic / therapy*
  • Magnetic Resonance Imaging
  • Male
  • Neuroimaging
  • Outcome Assessment, Health Care
  • Retrospective Studies
  • Thalamus / pathology
  • Time-to-Treatment*